Diminished capacity to make treatment decision for COVID-19 vaccination in schizophrenia

Recent evidence suggests that people with schizophrenia are at high risk for severe COVID-19 and should be prioritized for vaccination. However, impaired decision-making capacities could negatively affect the uptake of COVID-19 vaccination in this population. Capacity to consent to COVID-19 vaccinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Raffard, Stéphane, Bayard, Sophie, Eisenblaetter, Margot, Tattard, Philippe, Attal, Jérôme, Laraki, Yasmine, Capdevielle, Delphine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059908/
https://www.ncbi.nlm.nih.gov/pubmed/35501605
http://dx.doi.org/10.1007/s00406-022-01413-9
_version_ 1784698404630167552
author Raffard, Stéphane
Bayard, Sophie
Eisenblaetter, Margot
Tattard, Philippe
Attal, Jérôme
Laraki, Yasmine
Capdevielle, Delphine
author_facet Raffard, Stéphane
Bayard, Sophie
Eisenblaetter, Margot
Tattard, Philippe
Attal, Jérôme
Laraki, Yasmine
Capdevielle, Delphine
author_sort Raffard, Stéphane
collection PubMed
description Recent evidence suggests that people with schizophrenia are at high risk for severe COVID-19 and should be prioritized for vaccination. However, impaired decision-making capacities could negatively affect the uptake of COVID-19 vaccination in this population. Capacity to consent to COVID-19 vaccination was assessed in 80 outpatients with schizophrenia. Using the MacArthur Competence Assessment Tool for Treatment, 56.3% of the sample were classified as having diminished capacity to consent to the vaccination. Diminished capacity to consent to COVID-19 vaccination was associated with lower vaccination rates, poorer cognition and higher level of psychotic symptoms. Developing interventions for enhancing informed consent for vaccination is urgent within this population.
format Online
Article
Text
id pubmed-9059908
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-90599082022-05-03 Diminished capacity to make treatment decision for COVID-19 vaccination in schizophrenia Raffard, Stéphane Bayard, Sophie Eisenblaetter, Margot Tattard, Philippe Attal, Jérôme Laraki, Yasmine Capdevielle, Delphine Eur Arch Psychiatry Clin Neurosci Short Communication Recent evidence suggests that people with schizophrenia are at high risk for severe COVID-19 and should be prioritized for vaccination. However, impaired decision-making capacities could negatively affect the uptake of COVID-19 vaccination in this population. Capacity to consent to COVID-19 vaccination was assessed in 80 outpatients with schizophrenia. Using the MacArthur Competence Assessment Tool for Treatment, 56.3% of the sample were classified as having diminished capacity to consent to the vaccination. Diminished capacity to consent to COVID-19 vaccination was associated with lower vaccination rates, poorer cognition and higher level of psychotic symptoms. Developing interventions for enhancing informed consent for vaccination is urgent within this population. Springer Berlin Heidelberg 2022-04-30 2023 /pmc/articles/PMC9059908/ /pubmed/35501605 http://dx.doi.org/10.1007/s00406-022-01413-9 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Short Communication
Raffard, Stéphane
Bayard, Sophie
Eisenblaetter, Margot
Tattard, Philippe
Attal, Jérôme
Laraki, Yasmine
Capdevielle, Delphine
Diminished capacity to make treatment decision for COVID-19 vaccination in schizophrenia
title Diminished capacity to make treatment decision for COVID-19 vaccination in schizophrenia
title_full Diminished capacity to make treatment decision for COVID-19 vaccination in schizophrenia
title_fullStr Diminished capacity to make treatment decision for COVID-19 vaccination in schizophrenia
title_full_unstemmed Diminished capacity to make treatment decision for COVID-19 vaccination in schizophrenia
title_short Diminished capacity to make treatment decision for COVID-19 vaccination in schizophrenia
title_sort diminished capacity to make treatment decision for covid-19 vaccination in schizophrenia
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059908/
https://www.ncbi.nlm.nih.gov/pubmed/35501605
http://dx.doi.org/10.1007/s00406-022-01413-9
work_keys_str_mv AT raffardstephane diminishedcapacitytomaketreatmentdecisionforcovid19vaccinationinschizophrenia
AT bayardsophie diminishedcapacitytomaketreatmentdecisionforcovid19vaccinationinschizophrenia
AT eisenblaettermargot diminishedcapacitytomaketreatmentdecisionforcovid19vaccinationinschizophrenia
AT tattardphilippe diminishedcapacitytomaketreatmentdecisionforcovid19vaccinationinschizophrenia
AT attaljerome diminishedcapacitytomaketreatmentdecisionforcovid19vaccinationinschizophrenia
AT larakiyasmine diminishedcapacitytomaketreatmentdecisionforcovid19vaccinationinschizophrenia
AT capdevielledelphine diminishedcapacitytomaketreatmentdecisionforcovid19vaccinationinschizophrenia

Ejemplares similares